Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Life Sci ; 169: 11-19, 2017 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-27888116

RESUMEN

Cancer patients often show a wasting syndrome for which there are little therapeutic options. Dietary polyphenols have been proposed for treating this syndrome, but their usefulness in cases associated with human papillomavirus (HPV)-induced cancers is unknown. We characterized HPV16-transgenic mice as a model of cancer cachexia and tested the efficacy of long-term oral supplementation with polyphenols curcumin and rutin. Both compounds were orally administered to six weeks-old HPV16-transgenic mice showing characteristic multi-step skin carcinogenesis, for 24weeks. Skin lesions and blood, liver and spleen inflammatory changes were characterized histologically and hematologically. Hepatic oxidative stress, skeletal muscle mass and the levels of muscle pro-inflammatory transcription factor NF-κB were also assessed. Skin carcinogenesis was associated with progressive, severe, systemic inflammation (leukocytosis, hepatitis, splenitis), significant mortality and cachexia. Curcumin and rutin totally suppressed mortality while reducing white blood cells and the incidence of splenitis and hepatitis. Rutin prevented muscle wasting more effectively than curcumin. Preservation of muscle mass and reduced hepatic inflammation were associated with down-regulation of the NF-κB canonical pathway and with reduced oxidative stress, respectively. These results point out HPV16-transgenic mice as a useful model for studying the wasting syndrome associated with HPV-induced cancers. Dietary NF-κB inhibitors may be useful resources for treating this syndrome.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Caquexia/tratamiento farmacológico , Curcumina/uso terapéutico , Papillomavirus Humano 16/inmunología , FN-kappa B/antagonistas & inhibidores , Rutina/uso terapéutico , Neoplasias Cutáneas/tratamiento farmacológico , Animales , Caquexia/complicaciones , Caquexia/patología , Caquexia/virología , Femenino , Humanos , Inflamación/complicaciones , Inflamación/tratamiento farmacológico , Inflamación/patología , Inflamación/virología , Ratones Transgénicos , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Músculo Esquelético/virología , FN-kappa B/inmunología , Piel/efectos de los fármacos , Piel/patología , Piel/virología , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Síndrome Debilitante/complicaciones , Síndrome Debilitante/tratamiento farmacológico , Síndrome Debilitante/patología , Síndrome Debilitante/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA